SFA-001

N/A

Report date: 2023/01/05 13:55:55
NME

Base Information

Drug NameSFA-001
Drug Alias NameSFA-001SFA-001N
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsG-protein coupled receptor modulators
TargetsNuclear factor NF-kappa-B complexG-protein coupled receptor
Therapy Area/IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTemple UniversitySFA Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSFA Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A